Myriad Pushing Ahead With Payors on GeneSight as Data From Large Randomized Study is Published

Jan 07, 2019

|

NEW YORK (GenomeWeb) – Myriad Genetics is hoping that data from a large randomized controlled study published last week on GeneSight will change the reimbursement prospects for the pharmacogenetic test, as well as shift the standard of care for treating depression.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Model of Discovery

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

Subcommittee Calls for More Funding

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Limit of Relevance

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

This Week in PLOS

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.

Menu